Cost-effectiveness of systematic chemotherapy for metastatic pancreatic cancer: a retrospective study using Japanese clinical data

Cost-effectiveness of systematic chemotherapy for metastatic pancreatic cancer: a retrospective study using Japanese clinical data

Abstract We compared the cost-effectiveness of gemcitabine plus nab-paclitaxel (GnP) and modified FOLFIRINOX (mFFX)—standard first-line treatments for metastatic pancreatic cancer in Japan. This retrospective cohort study included patients with metastatic pancreatic cancer treated at the National Ca...

Full description

Saved in:
Bibliographic Details
Main Authors: Akira Shinohara, Yuki Takumoto, Junko Tauchi, Koki Morishita, Toshikatsu Kawasaki, Manabu Akazawa
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Gemcitabine plus nab-paclitaxel
Modified FOLFIRINOX
Pancreatic cancer
Chemotherapy
Cost-effectiveness
Online Access:https://doi.org/10.1038/s41598-024-80549-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-024-80549-1

Similar Items